IP Library › Granted Patent US 12,396,855
Granted Patent B1
US 12,396,855 · App. 18/796,048 · Granted Aug 26, 2025

Systems, devices, and methods for reducing heart valve regurgitation

Inventor: Sai Muralidhar Padala (Decatur, GA)
Assignee: Nyra Medical, Inc.
A61F2/2466A61F2/2418A61B2017/00243
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,396,855
App. No.
18/796,048
Granted
Aug 26, 2025
Kind
B1
Abstract

Embodiments described herein relate to an implant delivery system for delivering an implant for reducing heart valve regurgitation. The implant delivery system may include an implant catheter disposed in an inner lumen of a guide catheter. The implant catheter may include one or more hypotubes disposed therein, each hypotube configured to receive an elongate member such as a braided tether. A distal end of the implant catheter may be coupled to an implant holder configured to receive the implant. The implant holder may define one or more channels, each channel configured to receive a portion of a respective elongate member. The elongate members configured to couple the implant to the implant holder and transition the implant between configurations. The implant configured to be disposed around a portion of a leaflet of a heart valve to improve coaptation of the heart valve.

Claims (48)

1. A system, comprising:

an implant configured to be coupled to a native heart valve leaflet of a heart of a patient to reduce valve regurgitation, the implant including (1) an atrial arm and a ventricular arm collectively movable between a closed position and an open position and defining a space sufficient to capture a free end of the native leaflet between the atrial arm and the ventricular arm, and (2) a leaflet enhancer;

an implant catheter including an implant holder at a distal end thereof, the implant holder including a distal portion and a proximal portion collectively defining an opening therebetween the proximal portion and the distal portion connected by a connector extending across a portion of the opening, the front side of the implant holder including an engagement surface, a first portion of the implant configured to be disposed in the opening between the distal and the proximal portion, a second portion of the implant configured to abut the engagement surface,

the proximal portion of the implant holder defining a pair of atrial channels configured to slidably receive an atrial tether, the atrial tether configured to be removably coupled to the atrial arm of the implant,

the proximal portion of the implant holder defining a first pair of ventricular channels configured to slidably receive a first portion of a ventricular tether, the distal portion of the implant holder defining a second pair of ventricular channels separate from the first pair of ventricular channels and configured to slidably receive a second portion of the ventricular tether such that the ventricular tether extends through the first pair of ventricular channels, outside of the implant holder, and through the second pair of ventricular channels, the ventricular tether configured to be removably coupled to the ventricular arm of the implant.

2. The system of claim 1 , wherein a portion of the leaflet enhancer is configured to extend laterally beyond the connector and a perimeter defined by the implant holder.

3. The system of claim 2 , wherein the leaflet enhancer is deformable such that the portion of the leaflet enhancer can extend beyond the connector.

4. The system of claim 1 , wherein tension applied to a proximal portion of the atrial tether moves the atrial arm of the implant toward the engagement surface.

5. The system of claim 4 , wherein tension is released from the proximal portion of the ventricular tether to move the ventricular arm of the implant closer to the atrial arm of the implant, thereby transitioning the implant from the open position towards the closed position.

6. The system of claim 1 , wherein tension applied to a proximal portion of the ventricular tether moves the ventricular arm of the implant away from the atrial arm of the implant, thereby transitioning the implant towards the open position.

7. The system of claim 1 , wherein the distal portion of the implant holder includes an atraumatic distal end.

8. The system of claim 1 , wherein the pair of atrial channels include a pair of atrial openings in the proximal portion of the implant holder,

the first pair of ventricular channels include a first pair of ventricular openings in the proximal portion of the implant holder,

the second pair of ventricular channels include a second pair of ventricular openings on a back side of the distal portion of the implant holder and a third pair of ventricular openings on a front side of the distal portion of the implant holder.

9. The system of claim 1 , wherein the pair of atrial channels and the first pair of ventricular channels are configured to receive a flushing fluid from a fluid source to prevent blood clots from forming therein.

10. The system of claim 1 , wherein the connector includes one or more hypotubes.

11. The system of claim 1 , wherein the atrial arm of the implant includes an atrial suture loop disposed thereon and the ventricular arm of the implant includes a ventricular suture loop disposed thereon, the atrial tether configured to be routed through the atrial suture loop to operably couple to the atrial tether to the atrial arm and the ventricular tether configured to be routed through the ventricular suture loop to operably couple the ventricular tether to the ventricular arm.

12. The system of claim 1 , wherein the implant holder includes a transparent material.

13. The system of claim 1 , wherein a distance between the proximal end and the distal end of the implant holder is adjustable.

14. A system, comprising:

an implant configured to be to delivered to a native heart valve leaflet of a heart of a patient to reduce valve regurgitation through a gap within the native heart valve, the implant including (1) an atrial arm and a ventricular arm collectively movable between a closed position and an open position and defining a space sufficient to capture a free end of the native leaflet B between the atrial arm and the ventricular arm, the ventricular arm being configured to move laterally relative to the atrial arm to define the space; and (2) a leaflet enhancer

an implant catheter including an implant holder at a distal end thereof, the implant holder configured to hold the implant to form a distal assembly, the implant holder defining a pair of atrial channels configured to slidably receive an atrial tether, the atrial tether configured to be removably coupled to the atrial arm of the implant, the implant holder defining a first pair of ventricular channels and a second pair of ventricular channels separate from the first pair of ventricular channels, the first pair of ventricular channels and the second pair of ventricular channels configured to slidably receive a ventricular tether, the ventricular tether configured to be removably coupled to the ventricular arm of the implant,

a maximum lateral dimension of the distal assembly being defined by the implant when the implant is in the closed position.

15. The system of claim 14 , wherein tension applied to a proximal portion of the ventricular tether moves the ventricular arm of the implant away from the atrial arm of the implant, thereby transitioning the implant towards the open position,

tension released from the proximal portion of the ventricular tether moves the ventricular arm of the implant closer to the atrial arm of the implant, thereby transitioning the implant from the open position towards the closed position.

16. The system of claim 14 , wherein the implant catheter is configured to be manipulated to position the implant, when the implant is coupled to the implant catheter in the closed position, near the gap within the native heart valve leaflet such that a level of regurgitation can be determined by performing at least one of fluoroscopy imaging or echocardiography.

17. The system of claim 14 , wherein a level of valve regurgitation can be determined when the implant is positioned near the gap within the native heart valve leaflet without capturing the free end of the native leaflet between the atrial arm and the ventricular arm.

18. The system of claim 14 , wherein the implant holder includes a distal portion and proximal portion separate from the distal portion, the distal portion and the proximal portion defining an opening therebetween and connected by a connector extending across the opening, a portion of the implant configured to be disposed in the opening.

19. The system of claim 18 , wherein the portion of the implant configured to be disposed in the opening is a first portion, a front side of the proximal portion of the implant holder includes an engagement surface, a second portion of the implant configured to abut the engagement surface.

20. The system of claim 18 , wherein a portion of the leaflet enhancer is configured to extend beyond the connector and a perimeter defined by the implant holder so that the maximum lateral dimension of the leaflet enhancer is greater than a maximum lateral dimension of the implant holder.

21. The system of claim 20 , wherein the leaflet enhancer is deformable such that the portion of the leaflet enhancer can extend beyond the connector.

22. The system of claim 18 , wherein the connector includes one or more hypotubes.

23. The system of claim 14 , wherein the implant holder includes a transparent material.

24. A method of coupling an implant to a native heart valve leaflet of a heart valve of a patient to reduce valve regurgitation, the implant including (1) a pair of arms movable between an at-rest closed position and a biased open position, the pair of arms in the biased open position defining a space therebetween sufficient to capture a free end of the native leaflet between the pair of arms, and (2) a leaflet enhancer, the method comprising:

positioning the implant in an opening defined by the heart valve without capturing the free end of the native heart valve leaflet between the pair of arms;

determining a level of valve regurgitation when the implant is positioned in the opening defined by the heart valve;

after determining the level of valve regurgitation, transitioning the implant from its closed position to the biased open position; and

transitioning the implant from the biased open position towards its closed position to clamp the free end of the native leaflet between the pair of arms.

25. The method of claim 24 , wherein the method further comprises:

inserting a steerable guide catheter having an implant catheter slidably and rotatably disposed therein through a vasculature of the patient such that a distal end of the guide catheter is disposed in an atrium of the heart, the implant being in its closed position and removably coupled to a distal end portion of the implant catheter during the inserting; and

with the guide catheter disposed within the atrium, advancing the implant catheter relative to the guide catheter to expose the implant within the atrium.

26. The method of claim 25 , wherein a cross-sectional area of the leaflet enhancer is greater than or equal to a distal end portion of the implant catheter such that the level of valve regurgitation can be determined without capturing the free end of the native leaflet between the pair of arms.

27. The method of claim 25 , wherein the implant catheter includes an implant holder disposed on a distal end thereof and configured to hold the implant, the implant holder including:

a distal portion and a proximal portion collectively defining an opening therebetween extending from a front side of the implant holder to a back side of the implant holder, the proximal portion and the distal portion connected by a connector extending across the opening, a portion of the implant configured to be disposed in the opening between the distal portion and the proximal portion.

28. The method of claim 27 , wherein determining the level of valve regurgitation includes performing fluoroscopy imaging, the implant being discernable from the implant holder when the fluoroscopy imaging is performed.

29. The method of claim 24 , wherein the determining the level of valve regurgitation includes performing at least one of fluoroscopy imaging of the heart or echocardiography while the implant is positioned in the opening defined by the heart valve.

30. The method of claim 24 , wherein the pair of arms includes a first arm and a second arm and the implant catheter includes a first tether coupled to the first arm and a second tether coupled to the second arm.

31. The method of claim 30 , wherein tension is not removed from the first tether and the second tether during the determining the level of valve regurgitation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: PADALA, SAI MURALI
To: NYRA MEDICAL, INC.
Reel/Frame 070390/0195 →
Continuity (1)
Provisional Application 63675682 · Jul 25, 2024
References Cited (289)
US 4556060A · Perlin · 1985 [cited by applicant]
US 6264691B1 · Gabbay · 2001 [cited by applicant]
US 7635329B2 · Goldfarb et al. · 2009 [cited by applicant]
US 8690939B2 · Miller et al. · 2014 [cited by applicant]
US 8758431B2 · Orlov et al. · 2014 [cited by applicant]
US 8926691B2 · Chau et al. · 2015 [cited by applicant]
US 8932348B2 · Solem et al. · 2015 [cited by applicant]
US 9011468B2 · Ketai et al. · 2015 [cited by applicant]
US 9089422B2 · Ryan et al. · 2015 [cited by applicant]
US 9254141B2 · Morris et al. · 2016 [cited by applicant]
US 9414918B2 · Chau et al. · 2016 [cited by applicant]
US 9474605B2 · Rowe et al. · 2016 [cited by applicant]
US 9510946B2 · Chau et al. · 2016 [cited by applicant]
US 9510948B2 · Padala · 2016 [cited by applicant]
US 9592118B2 · Khairkhahan et al. · 2017 [cited by applicant]
US 9592121B1 · Khairkhahan · 2017 [cited by applicant]
US 9662208B2 · Padala et al. · 2017 [cited by applicant]
US 9770330B2 · Maurer et al. · 2017 [cited by applicant]
US 9867704B2 · Lee et al. · 2018 [cited by applicant]
US 9907652B2 · Chau et al. · 2018 [cited by applicant]
US 9913717B2 · Chau et al. · 2018 [cited by applicant]
US 10123873B1 · Metchik et al. · 2018 [cited by applicant]
US 10136993B1 · Metchik et al. · 2018 [cited by applicant]
US 10231837B1 · Metchik et al. · 2019 [cited by applicant]
US 10517726B2 · Chau et al. · 2019 [cited by applicant]
US 10646342B1 · Marr et al. · 2020 [cited by applicant]
US 10779829B2 · Wei · 2020 [cited by applicant]
US 10799359B2 · Siegel et al. · 2020 [cited by applicant]
US 10813760B2 · Metchik et al. · 2020 [cited by applicant]
US 10874514B2 · Dixon et al. · 2020 [cited by applicant]
US 10905552B2 · Dixon et al. · 2021 [cited by applicant]
US 10905554B2 · Cao · 2021 [cited by applicant]
US 10912646B2 · Spence · 2021 [cited by applicant]
US 10918483B2 · Metchik et al. · 2021 [cited by applicant]
US 10925734B2 · Delgado et al. · 2021 [cited by applicant]
US 10932908B2 · Dixon et al. · 2021 [cited by applicant]
US 11020229B2 · Delgado et al. · 2021 [cited by applicant]
US 11083582B2 · McCann et al. · 2021 [cited by applicant]
US 11141158B2 · Ketai et al. · 2021 [cited by applicant]
US 11259927B2 · Metchik et al. · 2022 [cited by applicant]
US 11278409B2 · McCann et al. · 2022 [cited by applicant]
US 11399940B2 · Spence · 2022 [cited by applicant]
US 11484331B2 · Goldfarb et al. · 2022 [cited by applicant]
US 11559401B2 · Spence · 2023 [cited by applicant]
US 11571305B2 · Padala et al. · 2023 [cited by applicant]
US 11602431B2 · Delgado et al. · 2023 [cited by applicant]
US 11660185B2 · Chau et al. · 2023 [cited by applicant]
US 11723772B2 · Dixon et al. · 2023 [cited by applicant]
US 11730598B2 · Metchik et al. · 2023 [cited by applicant]
US 11766330B2 · McCann et al. · 2023 [cited by applicant]
US 11793629B2 · Solem · 2023 [cited by applicant]
US 11793642B2 · Chau et al. · 2023 [cited by applicant]
US 11839545B2 · Hauser et al. · 2023 [cited by applicant]
US 11850153B2 · Delgado et al. · 2023 [cited by applicant]
US 11911264B2 · Chau et al. · 2024 [cited by applicant]
US 11918469B2 · Metchik et al. · 2024 [cited by applicant]
US 11969346B2 · Cao · 2024 [cited by applicant]
US 11992199B2 · Chen et al. · 2024 [cited by applicant]
US 20030153946A1 · Kimblad · 2003 [cited by applicant]
US 20040093023A1 · Allen et al. · 2004 [cited by applicant]
US 20040220593A1 · Greenhalgh · 2004 [cited by applicant]
US 20050159810A1 · Filsoufi · 2005 [cited by applicant]
US 20050216039A1 · Lederman · 2005 [cited by applicant]
US 20060241745A1 · Solem · 2006 [cited by applicant]
US 20060293698A1 · Douk · 2006 [cited by applicant]
US 20070118151A1 · Davidson · 2007 [cited by applicant]
US 20070197858A1 · Goldfarb et al. · 2007 [cited by applicant]
US 20080051807A1 · St. Goar et al. · 2008 [cited by applicant]
US 20080195126A1 · Solem · 2008 [cited by applicant]
US 20090043381A1 · Macoviak et al. · 2009 [cited by applicant]
US 20090276040A1 · Rowe et al. · 2009 [cited by applicant]
US 20110077733A1 · Solem · 2011 [cited by applicant]
US 20120197388A1 · Khairkhahan et al. · 2012 [cited by applicant]
US 20130053950A1 · Rowe et al. · 2013 [cited by applicant]
US 20140067048A1 · Chau et al. · 2014 [cited by applicant]
US 20140371766A1 · Morris et al. · 2014 [cited by applicant]
US 20150119981A1 · Khairkhahan et al. · 2015 [cited by applicant]
US 20150230919A1 · Chau et al. · 2015 [cited by applicant]
US 20150366566A1 · Kuntz · 2015 [cited by applicant]
US 20150366666A1 · Khairkhahan et al. · 2015 [cited by applicant]
US 20160157862A1 · Hernandez et al. · 2016 [cited by applicant]
US 20160287387A1 · Wei · 2016 [cited by applicant]
US 20160317290A1 · Chau et al. · 2016 [cited by applicant]
US 20160331523A1 · Chau et al. · 2016 [cited by applicant]
US 20170020521A1 · Krone et al. · 2017 [cited by applicant]
US 20170056176A1 · Rowe et al. · 2017 [cited by applicant]
US 20170189186A1 · Mohl · 2017 [cited by applicant]
US 20170258589A1 · Pham et al. · 2017 [cited by applicant]
US 20180147054A1 · Chau et al. · 2018 [cited by applicant]
US 20180161159A1 · Lee et al. · 2018 [cited by applicant]
US 20180185154A1 · Cao · 2018 [cited by applicant]
US 20180256318A1 · Khairkhahan et al. · 2018 [cited by applicant]
US 20190142589A1 · Basude · 2019 [cited by applicant]
US 20190201191A1 · McLean et al. · 2019 [cited by applicant]
US 20190282364A1 · Khairkhahan et al. · 2019 [cited by applicant]
US 20190343623A1 · Chau et al. · 2019 [cited by applicant]
US 20190343624A1 · Chau et al. · 2019 [cited by applicant]
US 20200060818A1 · Geist et al. · 2020 [cited by applicant]
US 20200138569A1 · Basude et al. · 2020 [cited by applicant]
US 20200205978A1 · Padala et al. · 2020 [cited by applicant]
US 20200222185A1 · Kappetein et al. · 2020 [cited by applicant]
US 20200229918A1 · Pham et al. · 2020 [cited by applicant]
US 20200229919A1 · Geist et al. · 2020 [cited by applicant]
US 20200268512A1 · Mohl · 2020 [cited by applicant]
US 20200275974A1 · Gifford, III et al. · 2020 [cited by applicant]
US 20200289265A1 · Gifford, III et al. · 2020 [cited by applicant]
US 20200405477A1 · Chau et al. · 2020 [cited by applicant]
US 20210038376A1 · Metchik et al. · 2021 [cited by applicant]
US 20210085462A1 · Gifford, III et al. · 2021 [cited by applicant]
US 20210145582A1 · Cao · 2021 [cited by applicant]
US 20210154005A1 · Metchik et al. · 2021 [cited by applicant]
US 20210196462A1 · Khairkhahan · 2021 [cited by applicant]
US 20210338418A1 · Feld · 2021 [cited by applicant]
US 20210346023A1 · Krone et al. · 2021 [cited by applicant]
US 20210353418A1 · Mohl · 2021 [cited by applicant]
US 20220000621A1 · Gifford, III et al. · 2022 [cited by applicant]
US 20220008201A1 · Passman et al. · 2022 [cited by applicant]
US 20220054132A1 · Ketai et al. · 2022 [cited by applicant]
US 20220079755A1 · Zimmerman, III et al. · 2022 [cited by applicant]
US 20220096236A1 · Guidotti et al. · 2022 [cited by applicant]
US 20220160499A1 · Miyashiro et al. · 2022 [cited by applicant]
US 20220160508A1 · Miyashiro et al. · 2022 [cited by applicant]
US 20220183839A1 · Khairkhahan et al. · 2022 [cited by applicant]
US 20220192822A1 · McLean et al. · 2022 [cited by applicant]
US 20220240920A1 · Goldfarb et al. · 2022 [cited by applicant]
US 20220346993A1 · Srinimukesh et al. · 2022 [cited by applicant]
US 20220409235A1 · Solem et al. · 2022 [cited by applicant]
US 20220409372A1 · Khairkhahan et al. · 2022 [cited by applicant]
US 20230132907A1 · McLean et al. · 2023 [cited by applicant]
US 20230138388A1 · Padala et al. · 2023 [cited by applicant]
US 20230142064A1 · Chau et al. · 2023 [cited by applicant]
US 20230181313A1 · Mohl et al. · 2023 [cited by applicant]
US 20230210663A1 · Solem et al. · 2023 [cited by applicant]
US 20230263624A1 · Chau et al. · 2023 [cited by applicant]
US 20230270549A1 · Guidotti et al. · 2023 [cited by applicant]
US 20230329866A1 · Spence · 2023 [cited by applicant]
US 20230346556A1 · Metchik et al. · 2023 [cited by applicant]
US 20230380971A1 · McCann et al. · 2023 [cited by applicant]
US 20240041602A1 · Chau et al. · 2024 [cited by applicant]
US 20240081988A1 · Desai et al. · 2024 [cited by applicant]
US 20240081999A1 · Metchik et al. · 2024 [cited by applicant]
US 20240164898A1 · Nir et al. · 2024 [cited by applicant]
US 20240245512A1 · Padala et al. · 2024 [cited by applicant]
US 20250064589A1 · Padala · 2025 [cited by applicant]
CN 115399920A · 2022 [cited by applicant]
JP 2008514307A · 2008 [cited by applicant]
JP 2017506973A · 2017 [cited by applicant]
WO WO2016042022A2 · 2016 [cited by applicant]
WO WO2019023138A1 · 2019 [cited by applicant]
WO WO2021011206A2 · 2021 [cited by applicant]
WO WO2022229667A1 · 2022 [cited by applicant]
WO WO2022250983A1 · 2022 [cited by applicant]
WO WO2023048918A1 · 2023 [cited by applicant]
WO WO2023100176A1 · 2023 [cited by applicant]
WO WO2023105334A1 · 2023 [cited by applicant]
WO WO2023114289A1 · 2023 [cited by applicant]
WO WO2024065977A1 · 2024 [cited by applicant]
WO WO2024174412A1 · 2024 [cited by applicant]
Agricola et al., “Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern” Eur J Echocardiogr. Oct. 2004; 5(5):326-334. [cited by applicant]
Agricola et al., “Ischemic mitral regurgitation: mechanisms and echocardiographic classification” Eur J Echocardiogr. Mar. 2008; 9(2):207-221. doi: 10.1016/j.euje.2007.03.034. [cited by applicant]
AHA/ACC Guideline Committee, “2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on… [cited by applicant]
Asgar et al., “Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations” J Am Coll Cardiol. Mar. 31, 2015; 65(12):1231-1248. [cited by applicant]
Baumgartner et al., “Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice” Eur J Echocardiogr. Jan. 2009; 10(1):1-25. [cited by applicant]
Bhudia et al., “Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings” Ann Thorac Surg. May 2004; 77(5):1598-1606. [cited by applicant]
Blondheim et al., “Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus” Am Heart J. Sep. 1991; 122(3 Pt 1):763-771. [cited by applicant]
Bloodworth et al., “Ex Vivo Methods for Informing Computational Models of the Mitral Valve” Ann Biomed Eng. Feb. 2017; 45(2):496-507. [cited by applicant]
Boerlage-Van Dijk et al., “Mitral inflow patterns after MitraClip implantation at rest and during exercise” J Am Soc Echocardiogr. Jan. 2014; 27(1):24-31.e1. [cited by applicant]
Bonow et al., “2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee” J Am Coll … [cited by applicant]
Carpentier, “Cardiac valve surgery—the “French correction”” J Thorac Cardiovasc Surg. Sep. 1983; 86(3):323-337. [cited by applicant]
Chan et al., “Real-world experience of MitraClip for treatment of severe mitral regurgitation” Circ J. (2012); 76(10):2488-2493. [cited by applicant]
Crick et al., “Anatomy of the pig heart: comparisons with normal human cardiac structure” J Anat. Jul. 1998; 193(Pt 1):105-119. [cited by applicant]
Dal-Bianco et al., “Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography” Cardiol Clin. May 2013; 31(2):151-164. [cited by applicant]
Dal-Bianco et al., “Basic mechanisms of mitral regurgitation” Can J Cardiol. Sep. 2014; 30(9):971-981. [cited by applicant]
De Bonis et al., “Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years?” Eur J Cardiothorac Surg. Sep. 2016; 50(3):48… [cited by applicant]
De Varennes et al., “Initial results of posterior leaflet extension for severe type IIIb ischemic mitral regurgitation” Circulation. Jun. 2, 2009; 119(21):2837-2843. [cited by applicant]
Dziadzko et al., “Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome” Eur Heart J. Jul. 14, 2019; 40(27):2194-2202. [cited by applicant]
Dziadzko et al., “Outcome and undertreatment of mitral regurgitation: a community cohort study” Lancet. Mar. 10, 2018; 391(10124):960-969. [cited by applicant]
English translation of Japanese Office Action issued in JP 2020-503766, dated Jul. 29, 2022, 6 pages. [cited by applicant]
English translation of Japanese Office Action issued in JP2023-109628, mailed May 23, 2024, 5 pages. [cited by applicant]
Espiritu et al., “Transcatheter Mitral Valve Repair Therapies: Evolution, Status and Challenges” Ann Biomed Eng. Feb. 2017; 45(2):332-359. [cited by applicant]
Extended European Search Report for European Application No. 24185624.4 mailed Oct. 16, 2024, 9 pages. [cited by applicant]
Feldman et al., “Assessing the Balance Between Less Mitral Regurgitation and More Residual Transmitral Pressure Gradient After MitraClip” JACC Cardiovasc Interv. May 8, 2017; 10(9):940-941. [cited by applicant]
Fukui et al., “Prior inferior myocardial infarction has worse early outcomes in patients undergoing coronary artery bypass grafting than prior anterior myocardial infarction” Ann Thorac Surg. Feb. 2009; 87(2):475-480. [cited by applicant]
Gaasch et al., “Left ventricular response to mitral regurgitation: implications for management” Circulation. Nov. 25, 2008; 118(22):2298-2303. [cited by applicant]
Garcia et al., “Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation” J Am Coll Cardiol. Feb. 1996; 27(2):399-406. [cited by applicant]
Goel et al., “Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need” J Am … [cited by applicant]
Gogoladze et al., “Analysis of the mitral coaptation zone in normal and functional regurgitant valves” Ann Thorac Surg. Apr. 2010; 89(4):1158-1161. [cited by applicant]
Goldstein et al., “Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation” N Engl J Med. Jan. 28, 2016; 374(4):344-353. [cited by applicant]
Gorman et al., “Infarct size and location determine development of mitral regurgitation in the sheep model” J Thorac Cardiovasc Surg. Mar. 1998; 115(3):615-622. [cited by applicant]
Grayburn et al., “Quantitation of mitral regurgitation” Circulation. Oct. 16, 2012; 126(16):2005-2017. [cited by applicant]
Hadjadj et al., “Echocardiographic Variables Associated with Transvalvular Gradient After a Transcatheter Edge-To-Edge Mitral Valve Repair” J Am Soc Echocardiogr. Jan. 2022; 35(1):86-95. [cited by applicant]
Harken et al., “The surgical correction of mitral insufficiency” J Thorac Surg. Dec. 1954; 28(6):604-624. [cited by applicant]
He et al., “Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies” Circulation. Sep. 16, 1997; 96(6):1826-1834. [cited by applicant]
Hensey et al., “Transcatheter Mitral Valve Replacement: An Update on Current Techniques, Technologies, and Future Directions” JACC Cardiovasc Interv. Mar. 8, 2021; 14(5):489-500. [cited by applicant]
Hilberath et al., “Intraoperative evaluation of transmitral pressure gradients after edge-to-edge mitral valve repair” PLoS One. Sep. 2, 2013; 8(9):e73617, 6 pages. [cited by applicant]
Ikenaga et al., “Mechanisms of mitral regurgitation after percutaneous mitral valve repair with the MitraClip” Eur Heart J Cardiovasc Imaging. Oct. 1, 2020; 21(10):1131-1143. [cited by applicant]
International Search Report and Written Opinion, issued in connection with International Application No. PCT/US18/43307, dated Oct. 2, 2018. 9 pages. [cited by applicant]
Itabashi et al., “Different indicators for postprocedural mitral stenosis caused by single- or multiple-clip implantation after percutaneous mitral valve repair” J Cardiol. Apr. 2018; 71(4):336-345. [cited by applicant]
Ito et al., “Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: A study using three-dimensional transesophageal echocardiography” J Cardiol. Dec. 2017; 70(6):584-590. [cited by applicant]
Johns et al., “Mitral insufficiency: the experimental use of a mobile polyvinyl sponge prosthesis” Ann Surg. Sep. 1954; 140(3):335-341. [cited by applicant]
Kaewkes et al., “Usefulness of Computed Tomography to Predict Mitral Stenosis After Transcatheter Mitral Valve Edge-to-Edge Repair” Am J Cardiol. Aug. 15, 2021; 153:109-118. [cited by applicant]
Kalra et al., “Temporal changes in interpapillary muscle dynamics as an active indicator of mitral valve and left ventricular interaction in ischemic mitral regurgitation” J Am Coll Cardiol. Nov. 4, 2014; 64(18):1867-18… [cited by applicant]
Kaplan et al., “Three-dimensional echocardiographic assessment of annular shape changes in the normal and regurgitant mitral valve” Am Heart J. Mar. 2000; 139(3):378-387. [cited by applicant]
Kaul et al., “Mechanism of ischemic mitral regurgitation. An experimental evaluation” Circulation. Nov. 1991; 84(5):2167-2180. [cited by applicant]
Kimura et al., “The unique mechanism of functional mitral regurgitation in acute myocardial infarction: a prospective dynamic 4D quantitative echocardiographic study” Eur Heart J Cardiovasc Imaging. Apr. 1, 2019; 20(4):… [cited by applicant]
Kincaid et al., “Anterior leaflet augmentation for ischemic mitral regurgitation” Ann Thorac Surg. Aug. 2004; 78(2):564-568. [cited by applicant]
Kron et al., “Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation” J Thorac Cardiovasc Surg. Mar. 2015; 149(3):752-761.e1. [cited by applicant]
Kumanohoso et al., “Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients wit… [cited by applicant]
Ladich et al., “Pathological healing response of explanted MitraClip devices” Circulation. Apr. 5, 2011; 123(13):1418-1427. [cited by applicant]
Lam et al., “Hemolysis after mitral valve repair: mechanisms and treatment” Ann Thorac Surg. Jan. 2004; 77(1):191-195. [cited by applicant]
Lam et al., “Morphology of the human mitral valve. I. Chordae tendineae: a new classification” Circulation. Mar. 1970; 41(3):449-458. [cited by applicant]
Lang et al., “Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging” J Am Soc Ec… [cited by applicant]
Lee et al., “Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering” Circulation. May 19, 2009; 119(19):2… [cited by applicant]
Levack et al., “Three-dimensional echocardiographic analysis of mitral annular dynamics: implication for annuloplasty selection” Circulation. Sep. 11, 2012; 126(11 Suppl 1):S183-S188. [cited by applicant]
Lubos et al., “MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome” JACC Cardiovasc Interv. Apr. 2014; 7(4):394-402. [cited by applicant]
Machino-Ohtsuka et al., “Novel Mechanistic Insights Into Atrial Functional Mitral Regurgitation—3-Dimensional Echocardiographic Study” Circ J. Sep. 23, 2016; 80(10):2240-2248. [cited by applicant]
Mack et al., “3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure” J Am Coll Cardiol. Mar. 2, 2021; 77(8):1029-1040. [cited by applicant]
Magne et al., “Ischemic mitral regurgitation: a complex multifaceted disease” Cardiology. (2009) 112(4):244-259. [cited by applicant]
Magne et al., “Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation” Circulation. Feb. 13, 2007; 115(6):782-791. [cited by applicant]
Magne et al., “Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis” J Am Coll Cardiol. Apr. 29, 2008; 51(17):1692-1701. [cited by applicant]
Maisano et al., “The edge-to-edge technique: a simplified method to correct mitral insufficiency” Eur J Cardiothorac Surg. Mar. 1998; 13(3):240-246. [cited by applicant]
Mann et al., “Mechanisms and models in heart failure: the biomechanical model and beyond” Circulation. May 31, 2005; 111(21):2837-2849. [cited by applicant]
Marchena et al., “Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development” J Card Surg. Jul. 2011; 26(4):385-392. [cited by applicant]
Marzilli et al., “Role of the papillary muscle in opening and closure of the mitral valve” Am J Physiol. Mar. 1980; 238(3):H348-H354. [cited by applicant]
Mauri et al., “The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation” Am Heart J. Jul. 2010; 160(1):23-29. [cited by applicant]
Mirabel et al., “What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?” Eur Heart J. Jun. 2007; 28(11):1358-1365. [cited by applicant]
MitraClip G4 Features—Tailored. Optimized. Proven. Accessed Sep. 5, 2024. https://mitraclip.com/physician/mitraclip-procedure/mitraclip-features. 10 pages. [cited by applicant]
Mitral Valve Repair Center, “Mitral Valve Function”, Accessed Apr. 19, 2022. https://www.mitralvalverepair.org/mitral-valve-function, 4 pages. [cited by applicant]
Mittal et al., “Combined papillary muscle and left ventricular wall dysfunction as a cause of mitral regurgitation. An experimental study” Circulation. Aug. 1971; 44(2):174-180. [cited by applicant]
Nagaura et al., “Percutaneous Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study” JACC Cardiovasc Imaging. Sep. 2019; 12(9):1881-1883. [cited by applicant]
Nematzadeh et al., “Effects of material properties on mechanical performance of nitinol stent designed for femoral artery: Finite element analysis” Sci. Iran. (2012) 19(6):1564-1571. [cited by applicant]
Neuss et al., “Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure” JACC Cardiovasc Interv. May 8, 20… [cited by applicant]
Nielsen et al., “Edge-to-edge mitral repair: tension on the approximating suture and leaflet deformation during acute ischemic mitral regurgitation in the ovine heart” Circulation. Sep. 18, 2001; 104(12 Suppl 1):129-35. [cited by applicant]
Nkomo et al., “Burden of valvular heart diseases: a population-based study” Lancet. Sep. 16, 2006; 368(9540):1005-1011. [cited by applicant]
Noack et al., “Changes in dynamic mitral valve geometry during percutaneous edge-edge mitral valve repair with the MitraClip system” J Echocardiogr. Jun. 2019; 17(2):84-94. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/089,127 mailed Aug. 29, 2024, 9 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/614,081 mailed on Aug. 30, 2024, 11 pages. [cited by applicant]
Obadia, J-F et al., “Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation,” New England Journal of Medicine, Dec. 2018, vol. 379, No. 24, pp. 2297-2306. [cited by applicant]
Odell et al., “Long-term results of the Ivalon baffle mitral valve repair” Ann Thorac Surg. Aug. 1992; 54(2):283-285. [cited by applicant]
Onishi et al., “Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome” Circ Heart Fail. Jul. 2013; 6(4):685-693. [cited by applicant]
Onohara et al., “Image-Guided Targeted Mitral Valve Tethering with Chordal Encircling Snares as a Preclinical Model of Secondary Mitral Regurgitation” J Cardiovasc Transl Res. Jun. 2022; 15(3):653-665. [cited by applicant]
Onohara et al., “Mitral regurgitation worsens cardiac remodeling in ischemic cardiomyopathy in an experimental model” J Thorac Cardiovasc Surg. Sep. 2020; 160(3):e107-e125. [cited by applicant]
Ooms et al., “Transcatheter Edge-to-Edge Repair in Proportionate Versus Disproportionate Functional Mitral Regurgitation” J Am Soc Echocardiogr. Jan. 2022; 35(1):105-115.e8. [cited by applicant]
Otsuji et al., “Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry” Circulation. Sep. 16, 1997; 96(… [cited by applicant]
Otsuji et al., “Restricted diastolic opening of the mitral leaflets in patients with left ventricular dysfunction: evidence for increased valve tethering” J Am Coll Cardiol. Aug. 1998; 32(2):398-404. [cited by applicant]
Otto et al., “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines”… [cited by applicant]
Padala et al., (Oct. 16, 2016). MitraPlug: Transcatheter leaflet extending for mitral & tricuspid repair [PowerPoint presentation], TCT Conference, Cardiovascular Research Foundation, Washington D.C., 16 pages. [cited by applicant]
Padala, “The arithmetic of a successful mitral valve repair” J Thorac Cardiovasc Surg. Nov. 2017; 154(5):1638-1640. [cited by applicant]
Pelton et al., “Optimization of processing and properties of medical grade Nitinol wire” Min Invas Ther & Allied Technol (2000) 9(1) 107-118. [cited by applicant]
Pibarot et al., “MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results” Eur Heart J Cardiovasc Imaging. Jun. 1, 2019; 20(6):620-624. [cited by applicant]
Ranganathan et al., “Morphology of the human mitral valve. II. The value leaflets” Circulation. Mar. 1970; 41(3):459-467. [cited by applicant]
Rassi et al., “Differing mechanisms of exercise flow augmentation at the mitral and aortic valves” Circulation. Mar. 1988; 77(3):543-551. [cited by applicant]
Reid et al., “Geometric differences of the mitral valve apparatus in atrial and ventricular functional mitral regurgitation” J Cardiovasc Comput Tomogr. Sep.-Oct. 2022; 16(5):431-441. [cited by applicant]
Rogers et al., “Early experience with Millipede IRIS transcatheter mitral annuloplasty” Ann Cardiothorac Surg. Nov. 2018; 7(6):780-786. [cited by applicant]
Rossi et al., “Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy” Heart. Oct… [cited by applicant]
Rumel et al., “The correction of mitral insufficiency with a transvalvular polyvinyl formalinized plastic (ivalon) sponge prosthesis; a preliminary report” Dis Chest. Apr. 1958; 33(4):401-413. [cited by applicant]
Search Report, issued in EP Application No. 18837757.6, dated Mar. 31, 2021. 8 pages. [cited by applicant]
Shah et al., “Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives” Front Cardiovasc Med. Jul. 2019 12:6:88. 18 pages. [cited by applicant]
Shi et al., “A Swine Model of Percutaneous Intracoronary Ethanol Induced Acute Myocardial Infarction and Ischemic Mitral Regurgitation” J Cardiovasc Transl Res. Aug. 2017; 10(4):391-400. [cited by applicant]
Sielicka et al., “Pathological Remodeling of Mitral Valve Leaflets from Unphysiologic Leaflet Mechanics after Undersized Mitral Annuloplasty to Repair Ischemic Mitral Regurgitation” J Am Heart Assoc. Nov. 6, 2018; 7(21)… [cited by applicant]
Silbiger, “A novel mechanism by which MitraClip implantation may favorably alter the natural history of left ventricular remodeling in patients with mitral regurgitation: proposed role of the ventricular-valvular loop” … [cited by applicant]
Silbiger, “Does left atrial enlargement contribute to mitral leaflet tethering in patients with functional mitral regurgitation? Proposed role of atriogenic leaflet tethering” Echocardiography. Nov. 2014; 31(10):1310-13… [cited by applicant]
Silbiger, “Mechanistic insights into atrial functional mitral regurgitation: Far more complicated than just left atrial remodeling” Echocardiography. Jan. 2019; 36(1):164-169. [cited by applicant]
Silbiger, “Mechanistic insights into ischemic mitral regurgitation: echocardiographic and surgical implications” J Am Soc Echocardiogr. Jul. 2011; 24(7):707-719. [cited by applicant]
Silverman et al., “The mitral complex. Interaction of the anatomy, physiology, and pathology of the mitral annulus, mitral valve leaflets, chordae tendineae, and papillary muscles” Am Heart J. Sep. 1968; 76(3):399-418. [cited by applicant]
Sorajja et al., “Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report” J Am Coll Cardiol. Nov. 7, 2017; 70(19):2315-2327. [cited by applicant]
Stone et al., “Transcatheter Mitral-Valve Repair in Patients with Heart Failure” N Engl J Med. Dec. 13, 2018; 379(24):2307-2318. [cited by applicant]
Sturla et al., “In vitro and in silico approaches to quantify the effects of the Mitraclip® system on mitral valve function” J Biomech. Jan. 5, 2017; 50:83-92. [cited by applicant]
Suresh, “Development of a Transcatheter Cardiac Leaflet Enhancer to Treat Functional Mitral Regurgitation” Dissertation May 2022, Georgia Institute of Technology, Emory University, 332 pages. [cited by applicant]
Sutton et al., “Left ventricular remodeling after myocardial infarction: pathophysiology and therapy” Circulation. Jun. 27, 2000; 101(25):2981-2988. [cited by applicant]
Szerlip et al. “2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study” JACC Cardiovasc Interv. Jul. 26, 2021; 14(14):1538-1548. [cited by applicant]
Templeton et al., “Experimental Reconstruction of Cardiac Valves by Venous and Pericardial Grafts” Ann Surg. Feb. 1949; 129(2):161-176. [cited by applicant]
Utsunomiya et al., “Comparison of mitral valve geometrical effect of percutaneous edge-to-edge repair between central and eccentric functional mitral regurgitation: clinical implications” Eur Heart J Cardiovasc Imaging.… [cited by applicant]
Utsunomiya et al., “Effect of Percutaneous Edge-to-Edge Repair on Mitral Valve Area and Its Association With Pulmonary Hypertension and Outcomes” Am J Cardiol. Aug. 15, 2017; 120(4):662-669. [cited by applicant]
Van Der Merwe et al., “Mitral Valve Replacement—Current and Future Perspectives” Open J Cardiovasc Surg. Jul. 13, 2017: 9:1179065217719023. 6 pages. [cited by applicant]
Van Rosendael et al., “New insights on Carpentier I mitral regurgitation from multidetector row computed tomography” Am J Cardiol. Sep. 1, 2014; 114(5):763-768. [cited by applicant]
Vokonas et al., “Dynamic geometry of the left ventricle in mitral regurgitation” Circulation. Oct. 1973; 48(4):786-796. [cited by applicant]
Votta et al., “3-D computational analysis of the stress distribution on the leaflets after edge-to-edge repair of mitral regurgitation” J Heart Valve Dis. Nov. 2002; 11(6):810-822. [cited by applicant]
Yoshida et al., “Impact of Percutaneous Edge-to-Edge Repair in Patients With Atrial Functional Mitral Regurgitation” Circ J. Jun. 25, 2021; 85(7):1001-1010. [cited by applicant]
Zahr et al., “Mitral Valve Repair with More Natural Physiologic Functionality of the Mitral Valve (Half-Moon)” Oregon Health & Science University (2021), TVT, 15 pages. [cited by applicant]
Zeng et al., “Asymmetric versus symmetric tethering patterns in ischemic mitral regurgitation: geometric differences from three-dimensional transesophageal echocardiography” J Am Soc Echocardiogr. Apr. 2014; 27(4):367-3… [cited by applicant]
Zhan-Moodie et al., “Papillary Muscle Approximation Reduces Systolic Tethering Forces and Improves Mitral Valve Closure in the Repair of Functional Mitral Regurgitation” JTCVS Open. Sep. 2021; 7:91-104. [cited by applicant]
Zoghbi et al., “Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic… [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2024/043651 mailed Jan. 21, 2025, 18 pages. [cited by applicant]
Invitation to Pay Additional fees for International Application No. PCT/US2024/043651, mailed Oct. 31, 2024, 3 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/782,496 mailed Feb. 24, 2025, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/782,496 mailed Nov. 13, 2024, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/089,127 mailed on Mar. 26, 2025, 7 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/614,081 mailed Jan. 2, 2025, 8 pages. [cited by applicant]
Cited By (3)
US 12,599,482 US 12,616,574 US 12,697,217